Cantor starts DarioHealth at OW; PT $35 - BioTuesdays

Feb 25, 2021 · Cantor Fitzgerald launched coverage of DarioHealth (NASDAQ:DRIO) with an “overweight” rating and price target of $35. The stock closed at $29.16 on Feb. 24. The stock …

$35
OFF

Cantor Starts DarioHealth At OW; PT $35 - BioTuesdays

1 week from now

Feb 25, 2021 · Cantor Fitzgerald launched coverage of DarioHealth (NASDAQ:DRIO) with an “overweight” rating and price target of $35. The stock closed at $29.16 on Feb. 24. The stock …

biotuesdays.com

$35
OFF

Consensus DarioHealth Corp. Börse Stuttgart - MarketScreener.com

1 week from now

Sep 30, 2021 · DARIOHEALTH : Cantor Fitzgerald Starts DarioHealth at Overweight With $35 Price Target 21-02-25: MT DARIOHEALTH : Alliance Global Partners Downgrades …

marketscreener.com

$35
OFF

Consensus DarioHealth Corp. - MarketScreener.com

1 week from now

DARIOHEALTH : Cantor Fitzgerald Starts DarioHealth at Overweight With $35 Price Target 21-02-25: MT DARIOHEALTH : Alliance Global Partners Downgrades DarioHealth to Neutral …

marketscreener.com

$7.50
OFF

Stifel Starts Coverage On 10 Rare Disease-focused Companies

1 week from now

Stifel starts coverage on 10 rare disease-focused companies. March 1, 2021 ... AGP ups Sensus Healthcare PT to $7.50 from $2.95. Cantor starts DarioHealth at OW; PT $35. You may also …

biotuesdays.com

$30
OFF

Cantor Starts Adlai Nortye At OW; PT $30 - BioTuesdays

1 week from now

Oct 25, 2023 · Cantor Fitzgerald launched coverage of Adlai Nortye (NASDAQ:ANL) with an “overweight” rating and price target of $30. The stock closed at $8.52 on Oct 24. The stock …

biotuesdays.com

$8
OFF

Cantor Starts PAVmed At OW; PT $8 | BioTuesdays : R/PAVM - Reddit

1 week from now

Posted by u/IvyMalise - 5 votes and no comments

reddit.com

$20
OFF

SVB Leerink Starts Lensar At OP; PT $20 - BioTuesdays

1 week from now

Feb 24, 2021 · Cantor starts DarioHealth at OW; PT $35. Cowen ups TransMedics PT to $44 from $20. You may also like. Markets. EF Hutton starts CytoSorbents at buy; PT $10. EF Hutton …

biotuesdays.com

$35
OFF

Cantor Starts Portage Biotech At OW; PT $35 - BioTuesdays

1 week from now

Aug 19, 2021 · Cantor Fitzgerald launched coverage of Portage Biotech (NASDAQ:PRTG) with an “overweight” rating and $35 price target. The stock closed at $18.95 on Aug. 18. Portage …

biotuesdays.com

$8
OFF

Cantor Starts Cardiol At OW; PT $8 - BioTuesdays

1 week from now

Dec 17, 2021 · Cantor Fitzgerald launched coverage of Cardiol Therapeutics (NASDAQ:CRDL) with an “overweight” rating and price target of $8. The stock closed at $1.87 on Dec. 16. …

biotuesdays.com

$4
OFF

Cantor Starts Mereo BioPharma At OW; PT $4 - BioTuesdays

1 week from now

Aug 12, 2022 · Cantor Fitzgerald initiated coverage of Mereo BioPharma (NASDAQ:MREO) with an “overweight” rating and $4 price target. The stock closed at $1.15 on Aug. 11. The stock …

biotuesdays.com

$15
OFF

Cantor Starts CareCloud At OW: PT $15 - BioTuesdays

1 week from now

Jun 11, 2021 · Cantor starts CareCloud at OW: PT $15. June 11, 2021. Cantor Fitzgerald launched coverage of CareCloud (NASDAQ:MTBC) with an “overweight” rating and $15 price …

biotuesdays.com

$40
OFF

Cantor Starts Annexon At OW; PT $40 - BioTuesdays

1 week from now

Sep 23, 2021 · Cantor Fitzgerald initiated coverage of Annexon (NASDAQ:ANNX) with an “overweight” rating and $40 price target. The stock closed at $21.12 on Sept. 22. Annexon is a …

biotuesdays.com

$50
OFF

Cantor Starts EFFECTOR Therapeutics At OW; PT $50 - BioTuesdays

1 week from now

Sep 13, 2021 · Cantor Fitzgerald launched coverage of eFFECTOR Therapeutics (NASDAQ:EFTR) with an “overweight” rating and price target of $50. The stock closed at …

biotuesdays.com

$58
OFF

Cantor Starts 89bio At OW; PT $58 - BioTuesdays

1 week from now

Apr 21, 2021 · Cantor Fitzgerald launched coverage of 89bio (NASDAQ:ETNB) with an “overweight” rating and $58 price target. The stock closed at $25.81 on April 20. 89bio is …

biotuesdays.com

$20
OFF

Cantor Starts Clarus Therapeutics At OW; PT $20 - BioTuesdays

1 week from now

Sep 20, 2021 · Cantor Fitzgerald initiated coverage of Clarus Therapeutics (NASDAQ:CRXT) with an “overweight” rating and $20 price target. The stock closed at $8.81 on Sept. 17. Clarus is …

biotuesdays.com

$11
OFF

Cantor Starts Aytu BioPharma At OW; PT $11 - BioTuesdays

1 week from now

Cantor Fitzgerald launched coverage of Aytu BioPharma (NASDAQ:AYTU) with an “overweight” rating and $11 price target. The stock closed at $7.49 on March 29. “Through a strategy of in …

biotuesdays.com